We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





New Microchip-Based Diagnostic System Rapidly Measures Amount of SARS-CoV-2 Antibodies in Blood

By LabMedica International staff writers
Posted on 03 Sep 2021
Print article
Image: The researchers developed a chip upon which key SARS-CoV-2 are fixed. A small drop of blood from the fingertip is necessary, and the sensitivity of the system is 500 times higher than that of conventional method (Photo courtesy of RIKEN Center for Emergent Matter Science)
Image: The researchers developed a chip upon which key SARS-CoV-2 are fixed. A small drop of blood from the fingertip is necessary, and the sensitivity of the system is 500 times higher than that of conventional method (Photo courtesy of RIKEN Center for Emergent Matter Science)
Researchers have developed a diagnostic system that can rapidly and sensitively measure the amount of antibodies in the blood that can protect us from SARS-CoV-2, the virus that causes COVID-19.

The diagnostic system for on-site measurement of antibodies against the COVID-19 virus was developed by a research team at the RIKEN Center for Emergent Matter Science (CEMS; Saitama, Japan) and is expected to enable efficient and precise testing of SARS-CoV-2 vaccine efficacy at medical facilities.

Currently, several vaccines against SARS-CoV-2 have been developed, and vaccination is being conducted worldwide. In the medical field, antibody tests using a technique called immunochromatography are performed to determine whether antibodies have been produced as a result of viral infection or vaccination. However, because the results of this test are determined by looking with the naked eye at colored stripes on paper, it is not precise and not very sensitive. To compound the problem, blood samples must be sent to an outside testing center for more precise, quantitative results, with turnaround taking several days to a week.

Several years ago, researchers at RIKEN CEMS had developed a technology that immobilizes any organic compound, including substances of biological origin. Since then, the team has continued to improve on the system, focusing on immobilizing various allergens to measure the history of immune infection. They have already succeeded in developing a test kit using a microchip that contains more than 40 different allergens immobilized on it. Now, they have expanded their diagnostic tools for use in a system that immobilizes several key SARS-CoV-2 proteins, allowing the presence of antibodies against SARS-CoV-2 to be detected automatically.

The technique is based on the use of light. A substance that reacts to light is first coated on a plastic microchip, and a sample liquid containing the protein of interest is dropped onto the microchip in the form of a spot. Then the chip is exposed to ultraviolet light, which immobilizes the proteins. Using this method, the researchers developed a chip called a microarray upon which key SARS-CoV-2 are fixed. When antibodies in blood serum bind to the viral proteins on the chip they emit light, and the amount of emitted light can be measured precisely with a CCD camera. This value can therefore, be used to quantify the number of antibodies in a way that is not possible with immunochromatography. Furthermore, its operation is quite simple – just drop human blood serum onto the chip, press the start button, and wait. The reaction process, washing, and antibody detection are performed automatically in about 30 minutes.

“Standard quantitative analysis of antibodies usually requires a half milliliter of blood drawn from one of your arms, which is a lot!,” said Yoshihiro Ito at RIKEN CEMS, who developed the technology and led the research team. “But in our system, all that is needed is a small drop of blood from the fingertip, and the sensitivity of the system is 500 times higher than that of conventional immunochromatography, meaning that detection is possible even when the number of antibodies is very low.”

“In the past, our team has succeeded in developing antibody detection systems for measles, rubella, and chicken pox. Now we can also detect antibodies for the COVID-19 virus. This system is practical to use and will enable precision testing at any medical facility, making it easier to quickly determine on-site whether or not vaccination is necessary. It can also be used to conduct epidemiological surveys in preparation for future pandemics,” added Ito.

Related Links:
RIKEN Center for Emergent Matter Science

New
Gold Supplier
SARS-CoV-2 Pooling Test
Vivalytic SARS-CoV-2 Pooling Test
New
Bulk Sorter
BL 1200 SORT CONNECT
New
Bench-Top Molecular Microarray System
NanoCHIP XL Analyzer
New
Anti-SARS-CoV-2 Controls Kit
ACCURUN Anti-SARS-CoV-2 Controls Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Pathology

view channel
Illustration

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.